SEC ownership of ACCENDRA HEALTH INC/VA/

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000075252.

Comparable stake leader

Coliseum Capital Management, LLC

Disclosed value leader

Coliseum Capital Management, LLC

Comparable rows

7/50

Latest evidence

05 Oct 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
7 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Coliseum Capital Management, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
05 Oct 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000075252
Issuer location
Glen Allen, VA

Ownership snapshot

Top shareholders of ACCENDRA HEALTH INC/VA/ (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Coliseum Capital Manageme...
Disclosed value leader
Coliseum Capital Manageme...
Comparable rows
7/50
Latest evidence
05 Oct 2026
3/4/5 13D/G 13F Lead comparable stake: 17% 43 rows are not safely comparable across share classes. 13D/G row: Coliseum Capital Management, LLC Showing 1-8 of 50 holder rows.

Quick read

Coliseum Capital Management, LLC leads the comparable SEC ownership view at 17%.

7 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Coliseum Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Coliseum Capital Management, LLC 17%
BANK OF AMERICA CORP /DE/ 11%
BlackRock, Inc. 7.1%
Kevin Michael Webb 5.6%
CHARLES SCHWAB INVESTMENT MANAGEM... 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Coliseum Capital Management, LLC
3/4/5 13D/G 13F
10%+ Owner · Company
17%
Reported 13D/G · 12 Nov 2025
$69,565,285
13,100,807 shares
— 12 Aug 2025
BANK OF AMERICA CORP /DE/
13F 13D/G
Company
11%
Reported 13D/G · 30 Sep 2026
$12,912,296
3,775,525 shares
— 30 Jun 2026
BlackRock, Inc.
13D/G 13F
Company
7.1%
Reported 13D/G · 30 Sep 2025
$29,888,199
5,454,051 shares
-$32,238,791 30 Sep 2025
Kevin Michael Webb
13D/G
Kevin M. Webb
5.6%
Reported 13D/G · 12 Mar 2026
$10,375,583
4,287,431 shares
$0 12 Mar 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F 13D/G
Company
4.8%
Reported 13D/G · 31 Mar 2026
$9,877,158
2,888,058 shares
— 30 Jun 2026
DIMENSIONAL FUND ADVISORS LP
13D/G 13F
Company
4.5%
Reported 13D/G · 30 Sep 2025
$16,836,283
3,507,559 shares
$0 30 Sep 2025
FMR LLC
13D/G 13F
Company
3.5%
Reported 13D/G · 31 Mar 2025
$18,895,342
2,718,754 shares
-$21,453,010 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$10,560,724
3,087,931 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 21 Oct 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 26 reporting-owner rows connected to ACCENDRA HEALTH INC/VA/. Open a relationship link for the CIK-to-CIK filing trail.

Rows
26
Largest Forms 3/4/5 holder
Coliseum Capital Management, LLC
Net 12M change
$0
Latest report
05 Oct 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Coliseum Capital Management, LLC 10%+ Owner $69,565,285 Filing P/S 12 Aug 2025
Nicholas J. Pace EVP, General Counsel $4,829,078 Mixed 15 May 2023
Christopher M. Lowery Former Pres, Global Products $4,196,730 Mixed 31 Mar 2022
Jochims Jeffrey T. EVP, COO and, President P&HS $3,542,884 Mixed 30 Jun 2022
Shana Carol Neal Chief Human Resources Officer $2,867,380 Mixed 04 Mar 2022
Mark F. Mcgettrick Director $2,481,538 Mixed 01 Jun 2022
Andrew G. Long Evp, Ceo P&Hs $2,470,821 Mixed 19 Nov 2025
Edward A. Pesicka President & CEO, Director $2,445,949 Mixed 15 May 2026
Daniel J. Starck EVP, Business Excellence $1,891,205 Mixed 15 May 2024
Mark P. Zacur EVP, Chief Commercial Officer $1,297,584 Mixed 03 Jun 2021
Kenneth Gardner-Smith President & CEO, Director $1,264,261 Mixed 05 Oct 2026
Jonathan A. Leon Evp & Cfo $979,036 Mixed 23 Sep 2026
Alexander J. Bruni Evp, Cfo $887,112 Filing P/S 03 Jun 2024
Michael Wayne Lowry SVP, Corporate Controller $853,447 Mixed 15 May 2025
Tammy L. Gomez Evp, Chro $845,819 Mixed 15 Aug 2023
Snehashish Sarkar Chief Information Officer $760,102 Mixed 15 May 2025
Perry A. Bernocchi EVP, Chief Operating Officer $715,721 Mixed 15 May 2026
Jennifer A. Stone Evp, Chro $700,576 Mixed 03 Jun 2025
Robert J. Henkel Director $538,013 Mixed 15 May 2025
Gwendolyn M. Bingham Director $418,159 Mixed 14 May 2026

Recent insider transactions for ACCENDRA HEALTH INC/VA/

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Kenneth Gardner-Smith ACH Common Stock Award 329.3% 283,554 369,667 05 Oct 2026 Direct
Jonathan A. Leon ACH Common Stock Tax liability -1.47% -4,265 286,268 23 Sep 2026 Direct
Heath H. Galloway ACH Common Stock Tax liability -1.08% -1,822 166,306 18 May 2026 Direct
Jonathan A. Leon ACH Common Stock Tax liability -0.61% -1,770 290,533 15 May 2026 Direct
Edward A. Pesicka ACH Common Stock Tax liability -1.62% -17,692 1,072,785 15 May 2026 Direct
Heath H. Galloway ACH Common Stock Tax liability -0.57% -966 168,128 15 May 2026 Direct
Perry A. Bernocchi ACH Common Stock Tax liability -2.46% -7,908 313,913 15 May 2026 Direct
Teresa L. Kline ACH Common Stock Award 57.6% 31,191 85,316 14 May 2026 Direct
Stephen W. Klemash ACH Common Stock Award 52.8% 31,191 90,242 14 May 2026 Direct
Kenneth Gardner-Smith ACH Common Stock Award 56.8% 31,191 86,113 14 May 2026 Direct
Gwendolyn M. Bingham ACH Phantom Stock Award 63.1% 31,191 80,603 14 May 2026 Direct
Mark A. Beck ACH Common Stock Award 77.8% 31,191 71,259 14 May 2026 Direct
Edward A. Pesicka ACH Common Stock Tax liability -5.13% -58,945 1,090,477 20 Mar 2026 Direct
Jonathan A. Leon ACH Common Stock Tax liability -3.72% -11,286 292,303 20 Mar 2026 Direct
Perry A. Bernocchi ACH Common Stock Tax liability -6.08% -20,841 321,821 20 Mar 2026 Direct
Heath H. Galloway ACH Common Stock Tax liability -5.24% -9,347 169,094 20 Mar 2026 Direct
Perry A. Bernocchi ACH Common Stock Award 46.5% 108,696 342,662 09 Mar 2026 Direct
Jonathan A. Leon ACH Common Stock Award 38.9% 85,067 303,589 09 Mar 2026 Direct
Heath H. Galloway ACH Common Stock Award 52.5% 61,437 178,441 09 Mar 2026 Direct
Andrew G. Long OMI Common Stock Gift -18.3% -47,908 214,064 19 Nov 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .